Ready to Scale, Ready to Fund - Session 2: Master your go-to-market and IP strategy
Ready to Scale, Ready to Fund is a four-session program for founders and teams building medical biotech, medtech and digital health companies. The series brings together practical pitch coaching, go-to-market and IP strategy, venture capital insights, corporate venturing and alternative financing options.
Across the four sessions, participants will strengthen how they present their company, connect scientific or technological innovation to a credible market pathway, and make more informed funding choices. The program is designed around the different development journeys of biotech and healthtech companies, while focusing on the questions investors and strategic partners consistently ask.
Session 2: Master your go-to-market and IP strategy
This session explores how companies move from promising innovation to a credible route to market. The discussion will reflect both biotech business models, including partnering and licensing pathways, and healthtech routes involving providers, payers, procurement, reimbursement, commercial partners and end users.
Program
- Go-to-market strategy and product-market fit
Defining the solution and target market; identifying customers, users, payers, partners and early adopters; validating market need; planning channels, reimbursement and partnerships. - IP strategy and investor readiness
Patents, know-how, trade secrets and data; alignment with the business model; freedom to operate; licensing; and how IP supports valuation and negotiation power. - Integrated expert discussion
Bringing market strategy and IP together: what investors look for, common pitfalls and how strategies evolve as companies grow or pivot. - Closing takeaways
Practical actions to strengthen investor readiness.
Ready to join?
The program is open to all Biovia members and HealthTech Investor Summit participants. *Hybrid access is available for participants based outside Belgium.
We encourage you to follow the full series to build progressively from pitch to market strategy and financing.
More info on the other session from the Ready to Scale, Ready to Fund series:
- Session 1: What investors really want to hear (27 October 2026, Online)
- Session 3: Corporate venturing and venture capital deep dive (17 November 2026, Antwerp - Hybrid*)
- Session 4: Funding beyond VCs (26 November 2026, Antwerp - Hybrid*)